Abstract:A series of novel chalcone analogs derived from syringaldehyde have been synthesized through acid or base-catalyzed aldol condensation. The anticancer activity of the newly synthesized compounds was assessed against a range of women-specific cancer cell lines, including A2780 (ovarian cancer), HeLa and C33a (cervical cancer), and MDA-MB-453, MDA-MB-231 and MCF-7 (breast cancer). The majority of these compounds demonstrated remarkable cytotoxicity against the tested cancer cells. Compound 2a displayed the most promising anti-proliferation activity against the selected female cancer cells, while also exhibiting the weakest cytotoxicity towards human normal cells. Therefore, it was chosen as the active compound based on both drug efficacy and safety considerations in this study. The findings indicated that compound 2a induced cell apoptosis and G2/M phase arrest by causing significant DNA damage and provoking a strong DNA damage response. Moreover, the results indicated that compound 2a affected the phosphorylation and distribution of FAK, thereby inhibiting cell adhesion and migration. Furthermore, compound 2a exhibited excellent potential in inhibiting A2780-derived xenograft tumor growth in mice, without any impact on their body weight. Tissue distribution experiments indicated that compound 2a tended to accumulate in the ovary in vivo. Overall, these results suggest that compound 2a may serve as a promising lead compound for developing anticancer agents against female cancer, especially in the case of ovarian cancer treatment.

Synthesis and Evaluation of Novel Isoxazolyl Chalcones As Potential Anticancer Agents.

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Synthesis and Anticancer Evaluation of 4-Anilinoquinolinylchalcone Derivatives

Synthesis, Molecular Modeling and Biological Evaluation of Chalcone Thiosemicarbazide Derivatives As Novel Anticancer Agents.

Synthesis and antitumor activity of novel chalcone derivatives.

Synthesis of quinoxalines and assessment of their inhibitory effects against human non-small-cell lung cancer cells

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Synthesis of Novel Xanthone Analogues and Their Growth Inhibitory Activity Against Human Lung Cancer A549 Cells

Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents

Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives

Synthesis and Evaluation in vitro of Dihydrothiophenopyridine-Chalcone Derivatives as Anticancer Activity Agents

Synthesis, anticancer evaluation of novel hybrid pyrazole-based chalcones, molecular docking, DNA fragmentation, and gene expression: in vitro studies

Synthesis and biological evaluation of the novel antitumor agent 3'-monosubstituted chalcone derivatives

Design, Synthesis, and Anticancer Activity of Novel Trimethoxyphenyl-Derived Chalcone-Benzimidazolium Salts

Synthesis, biological evaluation and in-silico ADMET studies of novel chalcones and dihydro pyrazoles of 2 H -Chromene as anticancer agents

Synthesis, characterization, and anticancer activity of syringaldehyde-derived chalcones against female cancers

Synthesis and crystal structure of chalcones as well as on cytotoxicity and antibacterial properties

Novel chalcone-derived pyrazoles as potential therapeutic agents for the treatment of non-small cell lung cancer

Synthesis of 2‐(pyridylvinyl)chromen‐4‐ones and their N‐oxide analogs for assessment of their biological activities as anticancer agents

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Synthesis of selenophene‐containing flavonols and 2‐styrylchromones: Evaluation of their activities compared with selenophene‐containing chalcones as potential anticancer agents